MOREL: Multicenter observational study on treatment and PD-L1 testing in patients (pts) with newly diagnosed stage IV NSCLC in Spain
dc.conference.date | DEC 09-12, 2020 | |
dc.conference.title | ESMO Immuno-Oncology Virtual Congress | |
dc.contributor.author | Rubio-Viqueira, B. | |
dc.contributor.author | Majem Tarruella, M. | |
dc.contributor.author | Lazaro, M. E. | |
dc.contributor.author | Vazquez Estevez, S. | |
dc.contributor.author | Cordoba-Ortega, J. F. | |
dc.contributor.author | Maestu Maiques, I. | |
dc.contributor.author | Garcia Gonzalez, J. J. | |
dc.contributor.author | Blasco Cordellat, A. | |
dc.contributor.author | Valdivia-Bautista, J. | |
dc.contributor.author | Gonzalez Arenas, C. | |
dc.contributor.author | Sanchez Torres, J. M. | |
dc.contributor.authoraffiliation | [Rubio-Viqueira, B.] Hosp Univ Quironsalud Madrid, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Majem Tarruella, M.] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Lazaro, M. E.] Hosp Univ Alvaro Cunqueiro, Dept Med Oncol, Vigo, Pontevedra, Spain | |
dc.contributor.authoraffiliation | [Vazquez Estevez, S.] Hosp Xeral Calde Lugo, Dept Med Oncol, Lugo, Spain | |
dc.contributor.authoraffiliation | [Cordoba-Ortega, J. F.] Hosp Arnau Vilanova, Dept Med Oncol, Lleida, Spain | |
dc.contributor.authoraffiliation | [Maestu Maiques, I.] Hosp Univ Doctor Peset, Dept Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Garcia Gonzalez, J. J.] CHUS Complejo Hosp Univ Santiago de Composteia, Dept Oncol Med, Santiago De Compostela, Spain | |
dc.contributor.authoraffiliation | [Blasco Cordellat, A.] Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Valdivia-Bautista, J.] Hosp Univ Virgen de las Nieves, Dept Med Oncol, Granada, Spain | |
dc.contributor.authoraffiliation | [Gonzalez Arenas, C.] MSD Merck Sharp & Dohme Espanola SA, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sanchez Torres, J. M.] Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain | |
dc.contributor.funder | Merck Sharp Dohme Spain | |
dc.date.accessioned | 2025-01-07T14:15:50Z | |
dc.date.available | 2025-01-07T14:15:50Z | |
dc.date.issued | 2020-12-01 | |
dc.identifier.doi | 10.1016/j.annonc.2020.10.542 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420430558/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/26250 | |
dc.identifier.wosID | 600992500055 | |
dc.issue.number | 7 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de las Nieves | |
dc.page.number | S1437-S1438 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | MOREL: Multicenter observational study on treatment and PD-L1 testing in patients (pts) with newly diagnosed stage IV NSCLC in Spain | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 31 | |
dc.wostype | Meeting Abstract |